{"nct_id":"NCT02561832","title":"A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer","status":"TERMINATED","status_verified_date":"2018-10","start_date":"2015-11-06","start_date_type":"ACTUAL","primary_completion_date":"2016-09-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}